The global market for cardiac surgery instruments, valued at USD 1.3 billion in 2022, is projected to reach USD 2.2 billion by 2032, with a predicted revenue compound annual growth rate (CAGR) of 5.6% during the forecast period. Key drivers of this revenue growth include the increasing prevalence of cardiovascular diseases, the aging global population, and a rise in healthcare expenditures....